Insight into novel clinical mutants of RpsA-S324F, E325K, and G341R of Mycobacterium tuberculosis associated with pyrazinamide resistance. [PDF]
Khan MT +4 more
europepmc +1 more source
Overcoming the pitfalls of automatic interpretation of whole genome sequencing data by online tools for the prediction of pyrazinamide resistance in Mycobacterium tuberculosis. [PDF]
Iwamoto T +11 more
europepmc +1 more source
Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru. [PDF]
Calderón RI +10 more
europepmc +1 more source
Predicting pyrazinamide resistance in Mycobacterium tuberculosis using a graph convolutional network
Dissanayake D +4 more
europepmc +1 more source
Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia. [PDF]
Sengstake S +8 more
europepmc +1 more source
pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia. [PDF]
Allana S +11 more
europepmc +1 more source
Pyrazinamide susceptibility testing in <i>Mycobacterium tuberculosis</i>: impact of false-positive BD MGIT 960 results and added value of sequencing for accurate diagnosis in a low-MDR-TB-incidence context. [PDF]
Semenova T +8 more
europepmc +1 more source
Convolutional neural networks quantify antibiotic resistance in Mycobacterium tuberculosis with diagnostic grade accuracy and predict treatment response. [PDF]
Kulkarni SG +11 more
europepmc +1 more source
Implementing shorter all-oral treatment durations for multidrug-resistant tuberculosis in the UK: from concept to application. [PDF]
Chavda A +4 more
europepmc +1 more source

